Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1887 1
1894 1
1903 2
1908 1
1909 1
1912 1
1919 1
1921 1
1926 1
1929 1
1931 1
1934 1
1936 1
1941 1
1942 1
1943 2
1944 1
1945 21
1946 71
1947 90
1948 103
1949 69
1950 76
1951 102
1952 124
1953 161
1954 167
1955 162
1956 167
1957 138
1958 135
1959 137
1960 112
1961 94
1962 133
1963 250
1964 265
1965 202
1966 177
1967 251
1968 234
1969 321
1970 284
1971 338
1972 340
1973 375
1974 428
1975 438
1976 434
1977 529
1978 460
1979 538
1980 702
1981 666
1982 601
1983 701
1984 784
1985 897
1986 889
1987 1075
1988 1132
1989 1068
1990 1218
1991 1276
1992 1415
1993 1657
1994 1990
1995 2037
1996 2341
1997 2701
1998 2751
1999 2966
2000 3474
2001 3501
2002 3792
2003 4544
2004 4992
2005 5312
2006 5556
2007 6386
2008 6714
2009 7024
2010 7711
2011 8672
2012 9339
2013 9777
2014 10308
2015 10454
2016 10650
2017 10714
2018 10724
2019 11325
2020 12200
2021 12729
2022 11948
2023 11446
2024 4066

Text availability

Article attribute

Article type

Publication date

Search Results

215,661 results

Results by year

Filters applied: . Clear all
Page 1
Genetics and biology of prostate cancer.
Wang G, Zhao D, Spring DJ, DePinho RA. Wang G, et al. Genes Dev. 2018 Sep 1;32(17-18):1105-1140. doi: 10.1101/gad.315739.118. Genes Dev. 2018. PMID: 30181359 Free PMC article. Review.
Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer remains largely incurable even after intensive multimodal therapy. The lethality of advanced disease is driven by the lack of therapeutic regimens capable of g …
Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer remains largely inc …
Complexities of Prostate Cancer.
Wasim S, Lee SY, Kim J. Wasim S, et al. Int J Mol Sci. 2022 Nov 17;23(22):14257. doi: 10.3390/ijms232214257. Int J Mol Sci. 2022. PMID: 36430730 Free PMC article. Review.
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer patient care and in the research field. The power of …
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In re …
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.
Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Sekhoacha M, et al. Molecules. 2022 Sep 5;27(17):5730. doi: 10.3390/molecules27175730. Molecules. 2022. PMID: 36080493 Free PMC article. Review.
Patients affected with prostate cancer present with either a localized or advanced disease. ...Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. ...
Patients affected with prostate cancer present with either a localized or advanced disease. ...Prostate cancer d …
High-risk prostate cancer-classification and therapy.
Chang AJ, Autio KA, Roach M 3rd, Scher HI. Chang AJ, et al. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20. Nat Rev Clin Oncol. 2014. PMID: 24840073 Free PMC article. Review.
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease. However, the current definitions of high-risk prostate cancer include a heterogeneous group of patients with a range of prognoses. ...This Review critically evalua …
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease. However, the current definitions of h …
Microbiota and prostate cancer.
Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Rizzo A, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):1058-1065. doi: 10.1016/j.semcancer.2021.09.007. Epub 2021 Sep 15. Semin Cancer Biol. 2022. PMID: 34536504 Review.
Prostate cancer remains the most frequently diagnosed non-skin malignancy in male patients, still representing one of the main causes of cancer-related death worldwide. ...However, few data are available regarding the interactions between prostate c …
Prostate cancer remains the most frequently diagnosed non-skin malignancy in male patients, still representing one of the main …
Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies.
Schatten H. Schatten H. Adv Exp Med Biol. 2018;1095:1-14. doi: 10.1007/978-3-319-95693-0_1. Adv Exp Med Biol. 2018. PMID: 30229546 Review.
This chapter provides a brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies that are discussed in more detail in the subsequent chapters of this book and the companion book titled "Clinical Molecular and Diagnostic Imaging of …
This chapter provides a brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies that are dis …
Prostate cancer between prognosis and adequate/proper therapy.
Grozescu T, Popa F. Grozescu T, et al. J Med Life. 2017 Jan-Mar;10(1):5-12. J Med Life. 2017. PMID: 28255369 Free PMC article. Review.
The risk of over-diagnosing and over-treating many prostate cancer cases (indicated by all the major European and American studies) is real and poses many question marks. The present paper was meant to deliver new research data and to reset the clinical approach in …
The risk of over-diagnosing and over-treating many prostate cancer cases (indicated by all the major European and American stu …
Diagnostic and Therapeutic Strategies for Prostate Cancer.
Nguyen-Nielsen M, Borre M. Nguyen-Nielsen M, et al. Semin Nucl Med. 2016 Nov;46(6):484-490. doi: 10.1053/j.semnuclmed.2016.07.002. Epub 2016 Sep 3. Semin Nucl Med. 2016. PMID: 27825428 Review.
Prostate cancer (PC) is a major disease that affects men's health worldwide. ...Diagnostic strategies with population screening for prostate cancer using prostate-specific antigen (PSA) has been surrounded with controversy and debated intensivel …
Prostate cancer (PC) is a major disease that affects men's health worldwide. ...Diagnostic strategies with population screenin …
[Locally advanced prostate cancer. Definition, diagnosis and treatment.].
Mayor de Castro J, Caño Velasco J, Aragón Chamizo J, Andrés Boville G, Herranz Amo F, Hernández Fernández C. Mayor de Castro J, et al. Arch Esp Urol. 2018 Mar;71(3):231-238. Arch Esp Urol. 2018. PMID: 29633943 Free article. Review. Spanish.
Prostate cancer is a disease that presents a wide spectrum from low aggressiveness localized to disseminated cancer. Locally advanced prostate cancer (LAPC) is a particularly difficult to manage phase of this spectrum. ...
Prostate cancer is a disease that presents a wide spectrum from low aggressiveness localized to disseminated cancer. Lo …
WNT signalling in prostate cancer.
Murillo-Garzón V, Kypta R. Murillo-Garzón V, et al. Nat Rev Urol. 2017 Nov;14(11):683-696. doi: 10.1038/nrurol.2017.144. Epub 2017 Sep 12. Nat Rev Urol. 2017. PMID: 28895566 Free article. Review.
Genome sequencing and gene expression analyses of prostate tumours have highlighted the potential importance of genetic and epigenetic changes observed in WNT signalling pathway components in prostate tumours - particularly in the development of castration-resistant …
Genome sequencing and gene expression analyses of prostate tumours have highlighted the potential importance of genetic and epigeneti …
215,661 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "prostate cancer"